Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-002563
Filing Date
2019-02-14
Accepted
2019-02-14 16:18:19
Documents
45
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1218_citiuspharma.htm 10-Q 205420
2 PATENT AND TECHNOLOGY LICENSE AGREEMENT, DATED JANUARY 2, 2019, BETWEEN THE BOAR f10q1218ex10-1_citius.htm EX-10.1 181942
3 FIRST AMENDMENT TO PATENT AND TECHNOLOGY LICENSE AGREEMENT f10q1218ex10-2_citius.htm EX-10.2 19791
4 PATENT AND TECHNOLOGY LICENSE AGREEMENT BETWEEN NOVEL ANTI-INFECTIVE TECHNOLOGIE f10q1218ex10-3_citius.htm EX-10.3 260374
5 CERTIFICATION f10q1218ex31-1_citius.htm EX-31.1 17126
6 CERTIFICATION f10q1218ex31-2_citius.htm EX-31.2 15584
7 CERTIFICATION f10q1218ex32-1_citius.htm EX-32.1 5398
  Complete submission text file 0001213900-19-002563.txt   2496722

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ctxr-20181231.xml EX-101.INS 275916
9 XBRL SCHEMA FILE ctxr-20181231.xsd EX-101.SCH 33101
10 XBRL CALCULATION FILE ctxr-20181231_cal.xml EX-101.CAL 33112
11 XBRL DEFINITION FILE ctxr-20181231_def.xml EX-101.DEF 116322
12 XBRL LABEL FILE ctxr-20181231_lab.xml EX-101.LAB 233662
13 XBRL PRESENTATION FILE ctxr-20181231_pre.xml EX-101.PRE 177963
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 19606615
SIC: 2834 Pharmaceutical Preparations